WINTON GROUP Ltd Reduces Stock Holdings in West Pharmaceutical Services, Inc. $WST

WINTON GROUP Ltd reduced its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 91.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,711 shares of the medical instruments supplier’s stock after selling 30,711 shares during the period. WINTON GROUP Ltd’s holdings in West Pharmaceutical Services were worth $973,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in the business. Greenleaf Trust grew its stake in shares of West Pharmaceutical Services by 4.1% during the second quarter. Greenleaf Trust now owns 843 shares of the medical instruments supplier’s stock worth $303,000 after acquiring an additional 33 shares during the last quarter. Wealth Alliance LLC increased its holdings in shares of West Pharmaceutical Services by 3.8% during the first quarter. Wealth Alliance LLC now owns 945 shares of the medical instruments supplier’s stock valued at $237,000 after acquiring an additional 35 shares in the last quarter. IFM Investors Pty Ltd raised its position in shares of West Pharmaceutical Services by 0.3% in the 1st quarter. IFM Investors Pty Ltd now owns 13,773 shares of the medical instruments supplier’s stock valued at $3,452,000 after purchasing an additional 43 shares during the last quarter. Compound Planning Inc. boosted its stake in West Pharmaceutical Services by 3.6% in the 1st quarter. Compound Planning Inc. now owns 1,224 shares of the medical instruments supplier’s stock worth $307,000 after purchasing an additional 43 shares in the last quarter. Finally, Aptus Capital Advisors LLC boosted its stake in West Pharmaceutical Services by 5.5% in the 4th quarter. Aptus Capital Advisors LLC now owns 905 shares of the medical instruments supplier’s stock worth $249,000 after purchasing an additional 47 shares in the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

Insider Activity at West Pharmaceutical Services

In other news, VP Annette Favorite sold 8,135 shares of the firm’s stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $340.81, for a total transaction of $2,772,489.35. Following the sale, the vice president owned 16,845 shares of the company’s stock, valued at $5,740,944.45. This trade represents a 32.57% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.60% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. TD Cowen restated a “buy” rating on shares of West Pharmaceutical Services in a research note on Wednesday, July 15th. UBS Group lifted their price objective on shares of West Pharmaceutical Services from $340.00 to $415.00 and gave the stock a “buy” rating in a research note on Wednesday, September 9th. Weiss Ratings raised shares of West Pharmaceutical Services from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, August 7th. Evercore reissued an “outperform” rating and issued a $425.00 target price on shares of West Pharmaceutical Services in a research report on Monday, July 27th. Finally, Stephens restated an “overweight” rating and issued a $360.00 target price on shares of West Pharmaceutical Services in a research note on Tuesday, June 2nd. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, West Pharmaceutical Services has a consensus rating of “Moderate Buy” and an average price target of $373.85.

West Pharmaceutical Services Stock Performance

NYSE WST opened at $345.49 on Monday. The firm has a market capitalization of $24.32 billion, a P/E ratio of 44.24, a PEG ratio of 2.42 and a beta of 1.14. The stock has a 50-day simple moving average of $348.46 and a two-hundred day simple moving average of $310.74. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.12 and a current ratio of 2.82. West Pharmaceutical Services, Inc. has a fifty-two week low of $223.83 and a fifty-two week high of $386.00.

West Pharmaceutical Services (NYSE:WST) last issued its earnings results on Thursday, July 23rd. The medical instruments supplier reported $2.37 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.29. The firm had revenue of $872.30 million for the quarter, compared to the consensus estimate of $839.98 million. West Pharmaceutical Services had a return on equity of 20.11% and a net margin of 16.98%.The company’s revenue was up 13.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.84 earnings per share. West Pharmaceutical Services has set its Q3 2026 guidance at 2.140-2.240 EPS and its FY 2026 guidance at 8.850-9.050 EPS. On average, equities analysts forecast that West Pharmaceutical Services, Inc. will post 8.93 earnings per share for the current year.

West Pharmaceutical Services Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 5th. Shareholders of record on Wednesday, July 29th were given a $0.22 dividend. This represents a $0.88 annualized dividend and a yield of 0.3%. The ex-dividend date was Wednesday, July 29th. West Pharmaceutical Services’s dividend payout ratio is currently 11.27%.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc (NYSE: WST) develops and manufactures components and systems used to package, contain and deliver injectable medicines and other healthcare products. Its customers include pharmaceutical, biotechnology and medical device companies, which use West products in drug administration and medical applications.

The company’s offerings include elastomer components such as stoppers, plungers and seals; syringe and cartridge components; vial and container closure systems; and specialized delivery systems for injectable and other complex medicines.